Solid Biosciences (SLDB) Net Income towards Common Stockholders Growth (5y) (2022 - 2026)
Solid Biosciences (SLDB) Net Income towards Common Stockholders Growth (5y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Solid Biosciences |
789.54 Mn |
408.86 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-26.73% |
| Dec 31, 2025 |
-17.26% |
| Sep 30, 2025 |
-16.27% |
| Jun 30, 2025 |
-15.36% |
| Mar 31, 2025 |
-7.22% |
| Dec 31, 2024 |
-3.50% |
| Sep 30, 2024 |
-2.36% |
| Jun 30, 2024 |
0.99% |
| Mar 31, 2024 |
3.99% |
| Dec 31, 2023 |
1.23% |
| Sep 30, 2023 |
-2.25% |
| Jun 30, 2023 |
-6.72% |
| Mar 31, 2023 |
-13.84% |
| Dec 31, 2022 |
-17.92% |
| Sep 30, 2022 |
-8.60% |
| Jun 30, 2022 |
-17.27% |
| Mar 31, 2022 |
-348.19% |
